On April 2nd, Dr. Hossam Mahmoud, Medical Director, Naveen Kathuria, SVP of Partnerships and Compliance and Kelly Jones, VP of Partnerships participated in a panel discussing Regulatory Frameworks of Prescribing Controlled Substances.
Some of the questions they answered include:
- What guidelines of the Ryan Haight Act and MAT legislation affects my practice?
- What exceptions apply to my facility and how can they be implemented?
- How does the Interstate Medical Licensure Compact impact clinician recruiting and expansion across state lines?
- Can telepsychiatrists prescribe controlled substances in my state?
For further reading on this topic and other telepsychiatry-related topics, read our new blog post, How Prescribing Suboxone Through Telepsychiatry Can Help Solve the Opioid Crisis, and download our Medication Assisted Treatment (MAT) Fact Sheet.
If you have any questions or would like to speak to someone at Regroup, contact us to be connected with the appropriate individual.